Evaluation and clinically relevant applications of a fluorescent imaging analog to fluorodeoxyglucose positron emission tomography

Journal of Biomedical Optics

Volumn 14, Issue 6, 2009, Pages

  Sheth, Rahul A ^a   Josephson, Lee ^a   Mahmood, Umar ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

FDG PET; Fluorescence biomarkers; Fluorescence endoscopy; Intraoperative imaging; Metabolic imaging; Minimally invasive imaging; Optical molecular imaging; Quantitative imaging

Indexed keywords

FDG-PET; FLUORESCENCE ENDOSCOPY; INTRA-OPERATIVE; METABOLIC IMAGING; MINIMALLY INVASIVE IMAGING; OPTICAL MOLECULAR IMAGING; QUANTITATIVE IMAGING;

AMINES; ANIMALS; ENDOSCOPY; FLUORESCENCE; GLUCOSE; METABOLISM; ONCOLOGY; SULFUR COMPOUNDS; TUMORS;

POSITRON EMISSION TOMOGRAPHY;

ANIMALIA; MUS;

2 (N (7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL)AMINO) 2 DEOXYGLUCOSE; 2-(N-(7-NITROBENZ-2-OXA-1,3-DIAZOL-4-YL)AMINO)-2-DEOXYGLUCOSE; 4 CHLORO 7 NITROBENZOFURAZAN; DEOXYGLUCOSE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; BRAIN; CELL STRAIN HT29; COLORECTAL TUMOR; HUMAN; MALE; METABOLISM; METHODOLOGY; MOUSE; NUDE MOUSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROSTATE TUMOR; REPRODUCIBILITY; SEIZURE; SPECTROFLUOROMETRY; TUMOR CELL LINE;

4-CHLORO-7-NITROBENZOFURAZAN; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DEOXYGLUCOSE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HT29 CELLS; HUMANS; INDICATORS AND REAGENTS; MALE; MICE; MICE, NUDE; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; SEIZURES; SPECTROMETRY, FLUORESCENCE;

EID: 70449864499     PISSN: 10833668     EISSN: 15602281     Source Type: Journal    
DOI: 10.1117/1.3259364     Document Type: Article

References (21)

1. S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. Silverman, R. E. Coleman, and M. E. Phelps, "A tabulated summary of the EDG PET literature," J. Nucl. Med. 42, (5 suppl), 1 S-93S (2001).
2. Z. Cheng, J. Levi, Z. Xiong, O. Gheysens, S. Keren, X. Chen, and S. S. Gambhir, "Near-infrared fluorescent deoxyglucose analogue for tumor optical imaging in cell culture and living mice," Bioconjugate Chem. 17(3), 662-669 (2006).
3. Y. Itoh, T. Abe, R. Takaoka, and N. Tanahashi, "Fluorometric determination of glucose utilization in neurons in vitro and in vivo," J. Cereb. Blood Flow Metab. 24(9), 993-1003 (2004).
4. K. Yamada, M. Nakata, N. Horimoto, M. Saito, H. Matsuoka, and N. Inagaki, "Measurement of glucose uptake and intracellular calcium concentration in single, living pancreatic beta-cells," J. Biol. Chem. 275(29), 22278-22283 (2000).
5. K. Yamada, M. Saito, H. Matsuoka, and N. Inagaki, "A real-time method of imaging glucose uptake in single, living mammalian cells," Nat. Protoč. 2(3), 753-762 (2007).
6. C. Zou, Y Wang, and Z. Shen, "2-NBDG as a fluorescent indicator for direct glucose uptake measurement," J. Biochem. Biophys. Methods 64(3), 207-215 (2005).
7. R. G. O'Neil, L. Wu, and N. Mullani, "Uptake of a fluorescent deoxyglucose analog (2-NBDG) in tumor cells," Mol. Imaging Biol. 7(6), 388-392 (2005).
8. R. Essner, E. C. Hsueh, P. I. Haigh, E. C. Glass, Y. Huynh, and F. Daghighian, "Application of an [(18)F]fluorodeoxyglucose-sensitive probe for the intraoperative detection of malignancy," J. Surg. Res. 96(1), 120-126 (2001).
9. A. E. Carpenter et al., "CellProfiler: image analysis software for identifying and quantifying cell phenotypes," Genome Biol. 7, R100 (2006).
10. M. M. Mirrione, W. K. Schiffer, M. Siddiq, S. L. Dewey, and S. E. Tsirka, "PET imaging of glucose metabolism in a mouse model of temporal lobe epilepsy," Synapse 59(2), 119-121 (2006).
11. W. A. Turski, E. A. Cavalheiro, M. Schwarz, S. J. Czuczwar, Z. Kleinrok, and L. Turski, "Limbic seizures produced by pilocarpine in rats: behavioural, electroencephalographic and neuropathological study," Behav. Brain Res. 9(3), 315-335 (1983).
12. Q. Huang, S. Shan, R. D. Braun, J. Lanzen, G. Anyrhambatla, G. Kong, M. Borelli, P. Corry, M. W Dewhirst, and C. Y. Li, "Noninvasive visualization of tumors in rodent dorsal skin window chambers," Nat. Biotechnol. 17(10), 1033-1035 (1999).
13. H. Alencar, U. Mahmood, Y Kawano, T. Hirata, and R. Weissleder, "Novel multiwavelength microscopic scanner for mouse imaging," Neoplasia 7(11), 977-983 (2005).
14. R. A. Sheth, R. Upadhyay, R. Weissleder, and U. Mahmood, "Realtime multichannel imaging framework for endoscopy, catheters, and fixed geometry intraoperative systems," Mol. Imaging 6(3), 147-155 (2007).
15. R. Upadhyay, R. A. Sheth, R. Weissleder, and U. Mahmood, "Quantitative real-time catheter-based fluorescence molecular imaging in mice," Radiology 245(2), 523-531 (2007).
16. M. A. Funovics, R. Weissleder, and U. Mahmood, "Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice," Radiology 231(3), 659-666 (2004).
17. J. Chen, C. H. Tung, U. Mahmood, V. Ntziachristos, R. Gyurko, M. C. Fishman, P. L. Huang, and R. Weissleder, "In vivo imaging of proteolytic activity in atherosclerosis," Circulation 105(23), 2766-2771 (2002).
18. J. Levi, Z. Cheng, O. Gheysens, M. Patel, C. T. Chan, Y. Wang, M. Namavari, and S. S. Gambhir, "Fluorescent fructose derivatives for imaging breast cancer cells," Bioconjugate Chem. 18(3), 628-634 (2007).
19. G. Dimitriadis, E. Maratou, E. Boutati, K. Psarra, C. Papasteriades, and S. A. Raptis, "Evaluation of glucose transport and its regulation by insulin in human monocytes using flow cytometry," Cytometry, Part A 64(1), 27-33 (2005).
20. S. W Ball, J. R. Bailey, J. M. Stewart, C. M. Vogels, and S. A. Westcott, "A fluorescent compound for glucose uptake measurements in isolated rat cardiomyocytes," Can. J. Physiol. Pharmacol. 80(3), 205-209 (2002).
21. K. Yoshioka, M. Saito, K. B. Oh, Y. Nemoto, H. Matsuoka, M. Natsume, and H. Abe, "Intracellular fate of 2-NBDG, a fluorescent probe for glucose uptake activity, in Escherichia coli cells," Biosci., Biotechnol, Biochem. 60(11), 1899-1901 (1996).